{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:15:22Z","timestamp":1791227722245,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.autrev.2011.11.002","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T11:39:28Z","timestamp":1320838768000},"page":"621-626","source":"Crossref","is-referenced-by-count":38,"title":["Macrophage folate receptor-\u03b2 (FR-\u03b2) expression in auto-immune inflammatory rheumatic diseases: A forthcoming marker for cardiovascular risk?"],"prefix":"10.1016","volume":"11","author":[{"given":"Nynke A.","family":"Jager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nato","family":"Teteloshvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark J.","family":"Zeebregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.11.002_bb0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1699-0463.1960.tb01155.x","article-title":"On the morphodynamics of coronary sclerosis of the heart","volume":"49","author":"Anitschkow","year":"1960","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.autrev.2011.11.002_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2008.08.039","article-title":"Atherosclerosis\u2013an immune disease: The Anitschkov Lecture 2007","volume":"202","author":"Hansson","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2011.11.002_bb0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2011.04.018","article-title":"The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk","volume":"10","author":"Gremese","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00428-006-0176-7","article-title":"Atherosclerosis research from past to present\u2013on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow","volume":"449","author":"Mayerl","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.autrev.2011.11.002_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2010.09.014","article-title":"Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality","volume":"10","author":"Nussinovitch","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.1990440","article-title":"Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis","volume":"251","author":"Cybulsky","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.autrev.2011.11.002_bb0035","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.11.002_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.11.002_bb0045","first-page":"301","article-title":"Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis","volume":"140","author":"Clinton","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0050","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1016\/j.febslet.2006.08.022","article-title":"Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development","volume":"580","author":"Pennings","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2011.11.002_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.60.6.561","article-title":"Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA","volume":"60","author":"Smeets","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.002_bb0060","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","article-title":"From endothelial dysfunction to atherosclerosis","volume":"9","author":"Sitia","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0065","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.autrev.2010.05.018","article-title":"Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?","volume":"9","author":"Zardi","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0070","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.11.002_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2011.11.002_bb0085","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.CIR.99.13.1726","article-title":"Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice","volume":"99","author":"Moulton","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.11.002_bb0090","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00048.2003","article-title":"Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture","volume":"85","author":"Newby","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0100","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.ATV.0000033517.48444.1A","article-title":"Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas\/Fas-L interactions","volume":"22","author":"Boyle","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0105","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2011.11.002_bb0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1517\/13543784.16.5.563","article-title":"Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease","volume":"16","author":"Husmann","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.autrev.2011.11.002_bb0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2011.11.002_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.11.002_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.0504272","article-title":"Functional plasticity of macrophages: reversible adaptation to changing microenvironments","volume":"76","author":"Stout","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1177\/41.10.7504008","article-title":"The immunohistochemical heterogeneity of atheroma macrophages: comparison with lymphoid tissues suggests that recently blood-derived macrophages can be distinguished from longer-resident cells","volume":"41","author":"Poston","year":"1993","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.autrev.2011.11.002_bb0155","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2353\/ajpath.2008.070513","article-title":"Heterogeneity of human macrophages in culture and in atherosclerotic plaques","volume":"172","author":"Waldo","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0160","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2353\/ajpath.2009.080431","article-title":"Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype","volume":"174","author":"Boyle","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2011.11.002_bb0170","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1369\/jhc.5A6871.2006","article-title":"AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype","volume":"54","author":"Komohara","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.autrev.2011.11.002_bb0175","doi-asserted-by":"crossref","first-page":"e8852","DOI":"10.1371\/journal.pone.0008852","article-title":"Macrophage plasticity in experimental atherosclerosis","volume":"5","author":"Khallou-Laschet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.11.002_bb0180","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.0713732","article-title":"M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro","volume":"182","author":"Leidi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0195","doi-asserted-by":"crossref","first-page":"e21803","DOI":"10.1371\/journal.pone.0021803","article-title":"Ligation of macrophage Fcgamma receptors recapitulates the gene expression pattern of vulnerable human carotid plaques","volume":"6","author":"Lennartz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.11.002_bb0200","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar1944","article-title":"Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis","volume":"8","author":"Paulos","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.002_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10555-007-9046-2","article-title":"Human reduced folate carrier: translation of basic biology to cancer etiology and therapy","volume":"26","author":"Matherly","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","article-title":"Membrane transport of folates","volume":"66","author":"Matherly","year":"2003","journal-title":"Vitam Horm"},{"key":"10.1016\/j.autrev.2011.11.002_bb0215","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0220","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1083\/jcb.110.3.637","article-title":"The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway","volume":"110","author":"Rothberg","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0225","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood.V93.11.3940","article-title":"Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells","volume":"93","author":"Reddy","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.11.002_bb0230","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4","article-title":"Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia","volume":"85","author":"Ross","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2011.11.002_bb0235","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1021\/bi00446a042","article-title":"Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA","volume":"28","author":"Ratnam","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2011.11.002_bb0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood-2008-04-150789","article-title":"A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages","volume":"113","author":"Xia","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.11.002_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.24219","article-title":"Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients","volume":"60","author":"van der Heijden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.002_bb0250","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1158\/0008-5472.CAN-09-2050","article-title":"Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory\/regulatory macrophages","volume":"69","author":"Puig-Kroger","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2011.11.002_bb0255","first-page":"253","article-title":"Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan","volume":"27","author":"Matteson","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0260","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.autrev.2010.08.001","article-title":"Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases","volume":"9","author":"Atzeni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0265","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2967\/jnumed.109.071324","article-title":"Imaging of atherosclerosis in apolipoprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages","volume":"51","author":"Ayala-Lopez","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.autrev.2011.11.002_bb0270","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/ar3312","article-title":"A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity","volume":"13","author":"Feng","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.002_bb0275","doi-asserted-by":"crossref","first-page":"e2078","DOI":"10.1371\/journal.pone.0002078","article-title":"Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype","volume":"3","author":"Gustafsson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.11.002_bb0280","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.002_bb0285","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.autrev.2010.06.001","article-title":"How early is the atherosclerotic risk in rheumatoid arthritis?","volume":"9","author":"Bartoloni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0290","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.autrev.2010.08.002","article-title":"Cardiac involvement in systemic rheumatic diseases: An update","volume":"9","author":"Sarzi-Puttini","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.002_bb0295","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00259-010-1697-5","article-title":"Molecular imaging of atherosclerosis in translational medicine","volume":"38","author":"Perrone-Filardi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.autrev.2011.11.002_bb0300","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cpcardiol.2010.09.002","article-title":"Noninvasive imaging of the vulnerable atherosclerotic plaque","volume":"35","author":"ten Kate","year":"2010","journal-title":"Curr Probl Cardiol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T08:38:24Z","timestamp":1593247104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1568997211002461"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.11.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}